Selegiline

Last Updated: 09/19/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3184 publications

Meta-analysis and pharmacoeconomic study of rasagiline versus selegiline in the treatment of Parkinson's disease.

Meta-analysis and pharmacoeconomic study of rasagiline versus selegiline in the treatment of Parkinson's disease.

Journal: Annals of medicine
Published: August 19, 2026

Design, Synthesis, and Preliminary Evaluation of Fluorinated Indazole-5-carboxamide Derivatives for MAO-B PET Imaging.

Design, Synthesis, and Preliminary Evaluation of Fluorinated Indazole-5-carboxamide Derivatives for MAO-B PET Imaging.

Journal: Journal of medicinal chemistry
Published: June 29, 2026

In vitro evaluation of monoamine oxidase and acetylcholinesterase enzyme activities of Capparis cartilaginea Decne.

In vitro evaluation of monoamine oxidase and acetylcholinesterase enzyme activities of Capparis cartilaginea Decne.

Journal: Natural product research
Published: June 26, 2026

Edge Exposure and Electrochemical Modulation of Graphene Oxide by Focused Cu Ion Bombardment.

Edge Exposure and Electrochemical Modulation of Graphene Oxide by Focused Cu Ion Bombardment.

Journal: Langmuir : the ACS journal of surfaces and colloids
Published: June 23, 2026

Diagnostic Reclassification From Parkinson's Disease to Multiple System Atrophy Based on Longitudinal Clinical and Imaging Findings: A Case Report.

Diagnostic Reclassification From Parkinson's Disease to Multiple System Atrophy Based on Longitudinal Clinical and Imaging Findings: A Case Report.

Journal: Cureus
Published: June 06, 2026

Evaluating Reduced Use and Abstinence as Outcomes in Pharmacotherapy Trials for Stimulant Use Disorder: A Meta-Analysis of 12 Randomized Controlled Trials.

Evaluating Reduced Use and Abstinence as Outcomes in Pharmacotherapy Trials for Stimulant Use Disorder: A Meta-Analysis of 12 Randomized Controlled Trials.

Journal: JAMA psychiatry
Published: June 03, 2026

Zembrin® Mitigates Reserpine-Induced Motor Dysfunction and Oxidative Stress in Parkinson's Disease: In Vivo and In Silico Analyses.

Zembrin® Mitigates Reserpine-Induced Motor Dysfunction and Oxidative Stress in Parkinson's Disease: In Vivo and In Silico Analyses.

Journal: Molecules (Basel, Switzerland)
Published: June 02, 2026

Wenshen Yanggan Decoction improves intestinal function in mouse models of Parkinson's disease by regulating intestinal bioactive substances

Wenshen Yanggan Decoction improves intestinal function in mouse models of Parkinson's disease by regulating intestinal bioactive substances

Journal: Nan fang yi ke da xue xue bao = Journal of Southern Medical University
Published: May 27, 2026

Reproducible Generalized Thermal Sensation Triggered by Levodopa in a Patient With Parkinson's Disease.

Reproducible Generalized Thermal Sensation Triggered by Levodopa in a Patient With Parkinson's Disease.

Journal: Journal of medical cases
Published: May 12, 2026

Chitosan Nanoparticles Co-Encapsulating Selegiline Analogue and L-Tyrosine Mitigate Depression-Related Pathology and Cognitive Decline in Rats.

Chitosan Nanoparticles Co-Encapsulating Selegiline Analogue and L-Tyrosine Mitigate Depression-Related Pathology and Cognitive Decline in Rats.

Journal: Biomolecules
Published: April 30, 2026

Loganin Attenuates Rotenone-Induced Parkinsonism-like Features in Rats Through Multi-Target Neuroprotective Mechanisms.

Loganin Attenuates Rotenone-Induced Parkinsonism-like Features in Rats Through Multi-Target Neuroprotective Mechanisms.

Journal: Biomedicines
Published: April 23, 2026

Microneedle assisted drug delivery of liposome loaded with selegiline hydrochloride for effective management of Parkinson's disease intervention.

Microneedle assisted drug delivery of liposome loaded with selegiline hydrochloride for effective management of Parkinson's disease intervention.

Journal: Journal of liposome research
Published: April 17, 2026
Showing 1-12 of 3,184

Last Updated: 09/19/2026